Arthur Allen, Jean Connors, Stephan Moll and Naomi Yates Explore Key Findings from The RENOVE and APICAT Trials
Anticoagulation Forum shared an inviting post on LinkedIn:
”Just 2 days away! Don’t miss our upcoming webinar: Secondary VTE Prevention: To Reduce or Not to Reduce?
Thursday, August 7 | 12:00 PM ET
We are excited to welcome another expert to our panel: Naomi Yates, PharmD, BCACP, who will join as a moderator to help guide this dynamic conversation on one of the most debated questions in anticoagulation: what’s the right dose, and when should it be reduced?
This live webinar will explore key findings from the RENOVE and API-CAT trials, framed by a historical lens and brought to life by a panel of expert clinicians.
What you’ll learn:
- DOAC dosing strategies for extended secondary VTE prevention
- Evidence-based guidance for individualizing care
- Practical takeaways for real-world treatment
Speakers:
Arthur Allen, PharmD, CACP
Jean Connors, MD
Stephan Moll, MD
Naomi Yates, PharmD, BCACP
There’s still time to register and bring your clinical questions to the panel.”
Register here.
Stay updated on all conferences, webinars and panel discussions on coagulation disorders with Hemostasis Today.
-
Jan 8, 2026, 05:51Dominika Jędrzejewska Akbaş Links Sleep Deprivation, Obesity, and Stroke
-
Jan 8, 2026, 05:42Rob Maloney: A Bruise that Did Not Go Away…
-
Jan 8, 2026, 05:33Matías J Alet on Treating Early Neurological Deterioration in Lacunar Stroke
-
Jan 8, 2026, 05:11Thomas Meinel Shares The English Stroke Guidelines 2026
-
Jan 8, 2026, 05:03Hilla Ben-Pazi: We Were Pleased to Receive a Grant from the Israeli Ministry of Economy
-
Jan 8, 2026, 04:24Nikhil Agrawal Breaks Down Perioperative Anticoagulation
-
Jan 8, 2026, 03:58Louise St Germain Bannon Appointed Interim Executive Director of ISTH
-
Jan 8, 2026, 03:47Wolfgang Miesbach on Fernando Corrales-Medina’s Team’s Latest Cross-Sectional Study on Haemophilia
-
Jan 8, 2026, 03:28Rick Matthews: Powerful Perspective from Erin and the NBCA Team